Thoughts on this? >> Theriva’s oncolytic virus succeeds in pancreatic cancer
study, but stock falls >> Comment below!
#strategy #competitiveintelligence #marketing #pharmaceutical #pharma #biotech #productmarketing #healthcare
Theriva’s oncolytic virus succeeds in pancreatic cancer
study, but stock falls
Theriva Biologics' experimental oncolytic virus treatment and chemotherapy helped patients in a mid-stage study stay alive longer than chemotherapy alone. The company said Wednesday that the Phase 2b study included 96 ...
